Literature DB >> 33479634

Argininamide-type neuropeptide Y Y1 receptor antagonists: the nature of N ω-carbamoyl substituents determines Y1R binding mode and affinity.

Jonas Buschmann1, Theresa Seiler1, Günther Bernhardt1, Max Keller1, David Wifling1.   

Abstract

The recently resolved crystal structure of the neuropeptide Y Y1 receptor (Y1R), co-crystallized with the high-affinity (pK i: 10.11), argininamide-type Y1R antagonist UR-MK299 (2), revealed that the N ω-carbamoyl substituent (van der Waals volume: 139 Å3) is deeply buried in the receptor, occupying a hydrophobic pocket. We synthesized and characterized a series of argininamides, structurally related to 2. Y1R affinity decreased with increasing size of the carbamoyl residue (minimal pK i: 5.67). Exceeding a critical size of the substituent (van der Waals volume: 212 Å3), the ligands bound in an inverted mode with the carbamoyl side chain located at the surface of the receptor, as suggested by induced-fit docking and MD simulations. This journal is © The Royal Society of Chemistry 2020.

Entities:  

Year:  2020        PMID: 33479634      PMCID: PMC7536821          DOI: 10.1039/c9md00538b

Source DB:  PubMed          Journal:  RSC Med Chem        ISSN: 2632-8682


  27 in total

1.  Chameleon labels for staining and quantifying proteins.

Authors:  Bianca K Wetzl; Sergiy M Yarmoluk; Douglas B Craig; Otto S Wolfbeis
Journal:  Angew Chem Int Ed Engl       Date:  2004-10-11       Impact factor: 15.336

2.  Red-fluorescent argininamide-type NPY Y1 receptor antagonists as pharmacological tools.

Authors:  Max Keller; Daniela Erdmann; Nathalie Pop; Nikola Pluym; Shangjun Teng; Günther Bernhardt; Armin Buschauer
Journal:  Bioorg Med Chem       Date:  2011-04-12       Impact factor: 3.641

3.  Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli.

Authors:  Pascal Egloff; Matthias Hillenbrand; Christoph Klenk; Alexander Batyuk; Philipp Heine; Stefanie Balada; Karola M Schlinkmann; Daniel J Scott; Marco Schütz; Andreas Plückthun
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-22       Impact factor: 11.205

4.  HTMD: High-Throughput Molecular Dynamics for Molecular Discovery.

Authors:  S Doerr; M J Harvey; Frank Noé; G De Fabritiis
Journal:  J Chem Theory Comput       Date:  2016-03-16       Impact factor: 6.006

5.  N(ω)-Carbamoylation of the Argininamide Moiety: An Avenue to Insurmountable NPY Y1 Receptor Antagonists and a Radiolabeled Selective High-Affinity Molecular Tool ([(3)H]UR-MK299) with Extended Residence Time.

Authors:  Max Keller; Stefan Weiss; Christoph Hutzler; Kilian K Kuhn; Catherine Mollereau; Stefanie Dukorn; Lisa Schindler; Günther Bernhardt; Burkhard König; Armin Buschauer
Journal:  J Med Chem       Date:  2015-11-04       Impact factor: 7.446

6.  Conjugation of Short Peptides to Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Determines M2R Selectivity.

Authors:  Andrea Pegoli; David Wifling; Corinna G Gruber; Xueke She; Harald Hübner; Günther Bernhardt; Peter Gmeiner; Max Keller
Journal:  J Med Chem       Date:  2019-05-22       Impact factor: 7.446

7.  Nε-Acryloyllysine Piperazides as Irreversible Inhibitors of Transglutaminase 2: Synthesis, Structure-Activity Relationships, and Pharmacokinetic Profiling.

Authors:  Robert Wodtke; Christoph Hauser; Gloria Ruiz-Gómez; Elisabeth Jäckel; David Bauer; Martin Lohse; Alan Wong; Johanna Pufe; Friedrich-Alexander Ludwig; Steffen Fischer; Sandra Hauser; Dieter Greif; M Teresa Pisabarro; Jens Pietzsch; Markus Pietsch; Reik Löser
Journal:  J Med Chem       Date:  2018-05-10       Impact factor: 7.446

8.  Synthesis and neuropeptide Y Y1 receptor antagonistic activity of N,N-disubstituted omega-guanidino- and omega-aminoalkanoic acid amides.

Authors:  M Müller; S Knieps; K Gessele; S Dove; G Bernhardt; A Buschauer
Journal:  Arch Pharm (Weinheim)       Date:  1997-11       Impact factor: 3.751

9.  Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets.

Authors:  J C Reubi; M Gugger; B Waser; J C Schaer
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

10.  Guanidinium and aminoimidazolinium derivatives of N-(4-piperidyl)propanamides as potential ligands for mu opioid and I2-imidazoline receptors: synthesis and pharmacological screening.

Authors:  Ana Montero; Pilar Goya; Nadine Jagerovic; Luis F Callado; J Javier Meana; Rocío Girón; Carlos Goicoechea; Ma Isabel Martín
Journal:  Bioorg Med Chem       Date:  2002-04       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.